It is injected by veterinarian or trained dog owner in the form of cyanocobalamin or hydroxocobalamin
The peptide demonstrates regional selectivity in its fat-reducing effects, showing particular efficacy in reducing visceral adipose tissue (deep abdominal fat) and subcutaneous fat deposits
This peptide has been studied for its potential role in supporting biological rhythm regulation and sleep wellness
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
B12 is generally safe when used under medical supervision
This increase in energy can support more active lifestyles and exercise, which is a key component of weight loss
